Immunoreactivity for sex steroid hormone receptors in pulmonary hamartomas

Research output: Contribution to journalArticlepeer-review


Sex steroid hormone [ie, estrogen (ER), progesterone (PgR), and androgen (AR)] receptors have been identified previously in normal salivary glands and, more variably, in salivary gland and salivary gland-type tumors. No data are available, however, on their expression in pulmonary hamartoma, a benign biphasic tumor consisting of reactive epithelial cells and neoplastic fibromyxoid stroma, cartilage and fat, which shares some morphologic, immunophenotypic, and genotypic features to pleomorphic adenoma of major salivary glands. Thirty pulmonary hamartomas (15 in male patients and 15 in age-matched female patients), were evaluated for ER, PgR, and AR immunoreactivity, and also for mesenchymal, epithelial, and myoepithelial markers, in the fibromyxoid, epithelial, and chondroid components. ER immunoreactivity was encountered in 90% of hamartomas, PgRs in 90%, and ARs in 53% (P

Original languageEnglish
Pages (from-to)819-827
Number of pages9
JournalAmerican Journal of Surgical Pathology
Issue number7
Publication statusPublished - Jul 2006


  • Androgen
  • Estrogen
  • Hamartoma
  • Immunohistochemistry
  • Lung
  • Myoepithelial
  • Progesterone
  • Receptors

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine


Dive into the research topics of 'Immunoreactivity for sex steroid hormone receptors in pulmonary hamartomas'. Together they form a unique fingerprint.

Cite this